AI Portfolio Summary
In 2025 Q4, Sio Capital Management, LLC maintained a portfolio of 77 distinct positions. The most significant new addition to the portfolio was THE CIGNA GROUP, which now represents 7.46% of the total fund value. Conversely, Sio Capital Management, LLC completely exited their position in MERCK & CO INC.
Total Positions
77
Quarter
2025 Q4
Top Holding
CELC (7.5%)
Top 10 Concentration
53.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 77
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CELC
CELCUITY INC
|
Healthcare | 7.48% | 9.83% |
#1
1
Prev: #2
|
3.1 | -309,459 | -39.3% |
P
S
|
477,067 | $47,582,663 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CI
THE CIGNA GROUP
|
Healthcare | 7.46% | — |
#2
Prev: #—
|
5.0 | 172,203 | no change |
NEW
|
172,203 | $47,395,432 | 2009 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNY
SANOFI SA
|
Healthcare | 7.41% | 6.72% |
#3
Prev: #3
|
5.2 | 408,983 | 72.7% |
P
S
|
971,686 | $47,087,904 | 2014 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MMS
MAXIMUS INC
|
Industrials | 6.79% | 12.89% |
#4
3
Prev: #1
|
2.7 | -57,311 | -10.3% |
P
S
|
500,304 | $43,186,241 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 5.45% | — |
#5
Prev: #—
|
4.2 | 385,642 | no change |
NEW
|
385,642 | $34,676,929 | 2009 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
PUT
RHYTHM PHARMACE...
|
PUT Option | 4.47% | — |
#6
Prev: #—
|
3.8 | 265,700 | no change |
NEW
|
265,700 | $28,440,528 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KVUE
KENVUE INC
|
Consumer Defensive | 3.98% | 3.47% |
#7
3
Prev: #10
|
3.8 | 621,442 | 73.6% |
P
S
|
1,465,442 | $25,278,875 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OGN
ORGANON & CO
|
Healthcare | 3.86% | — |
#8
Prev: #—
|
3.5 | 3,421,765 | no change |
NEW
|
3,421,765 | $24,534,055 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ICLR
ICON PLC
|
Healthcare | 3.65% | — |
#9
Prev: #—
|
3.5 | 127,202 | no change |
NEW
|
127,202 | $23,178,748 | 2017 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WAY
WAYSTAR HLDG CO...
|
Healthcare | 3.16% | — |
#10
Prev: #—
|
3.3 | 613,725 | no change |
NEW
|
613,725 | $20,099,494 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LIVN
LIVANOVA PLC
|
Healthcare | 3.12% | — |
#11
Prev: #—
|
3.2 | 322,382 | no change |
NEW
|
322,382 | $19,836,164 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 3.08% | 5.75% |
#12
8
Prev: #4
|
1.3 | -103,247 | -17.9% |
P
S
|
474,503 | $19,554,269 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 2.21% | — |
#13
Prev: #—
|
2.9 | 1,244,764 | no change |
NEW
|
1,244,764 | $14,053,386 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 2.20% | — |
#14
Prev: #—
|
2.9 | 201,500 | no change |
NEW
|
201,500 | $14,014,325 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 2.18% | 3.09% |
#15
4
Prev: #11
|
2.9 | 7,574 | 3.4% |
P
S
|
232,688 | $13,828,648 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 2.18% | 1.82% |
#16
3
Prev: #19
|
2.9 | 11,055 | 2.1% |
P
S
|
526,002 | $13,828,593 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 1.81% | — |
#17
Prev: #—
|
2.7 | 308,010 | no change |
NEW
|
308,010 | $11,534,975 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 1.78% | 3.50% |
#18
9
Prev: #9
|
0.8 | -113,250 | -29.2% |
P
S
|
274,350 | $11,289,503 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRL
CHARLES RIV LAB...
|
Healthcare | 1.73% | — |
#19
Prev: #—
|
2.7 | 54,985 | no change |
NEW
|
54,985 | $10,968,408 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TFX
TELEFLEX INCORP...
|
Healthcare | 1.67% | 1.24% |
#20
4
Prev: #24
|
3.0 | 46,819 | 116.9% |
P
S
|
86,876 | $10,602,347 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 1.47% | 2.02% |
#21
4
Prev: #17
|
2.6 | 102,040 | 5.8% |
P
S
|
1,874,641 | $9,354,459 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 1.44% | — |
#22
Prev: #—
|
2.6 | 1,715,394 | no change |
NEW
|
1,715,394 | $9,143,050 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CCRN
CROSS CTRY HEAL...
|
Healthcare | 1.36% | — |
#23
Prev: #—
|
2.5 | 1,068,821 | no change |
NEW
|
1,068,821 | $8,657,450 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HAE
HAEMONETICS COR...
|
Healthcare | 1.17% | 2.44% |
#24
10
Prev: #14
|
0.6 | -105,404 | -53.2% |
P
S
|
92,631 | $7,424,375 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 1.08% | 1.29% |
#25
3
Prev: #22
|
2.6 | 31,549 | 56.6% |
P
S
|
87,272 | $6,889,252 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRK
MERCK & CO INC
|
Healthcare | 0.00% | 3.77% |
Sold All 😨
(Was: #7) |
0.3 | -177,300 | -100.0% |
CLOSED
|
— | $— | 2009 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HSIC
HENRY SCHEIN IN...
|
Healthcare | 0.00% | 3.68% |
Sold All 😨
(Was: #8) |
0.3 | -219,207 | -100.0% |
CLOSED
|
— | $— | 2019 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GSK
GSK PLC
|
Healthcare | 0.00% | 2.94% |
Sold All 😨
(Was: #12) |
0.3 | -268,873 | -100.0% |
CLOSED
|
— | $— | 2014 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.00% | 2.11% |
Sold All 😨
(Was: #16) |
0.3 | -683,819 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVCR
NOVOCURE LTD
|
Healthcare | 0.00% | 1.35% |
Sold All 😨
(Was: #21) |
0.3 | -413,829 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLP
SIMULATIONS PLU...
|
Healthcare | 0.00% | 1.22% |
Sold All 😨
(Was: #25) |
0.3 | -320,307 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 0.00% | 0.90% |
Sold All 😨
(Was: #29) |
0.3 | -189,199 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ERAS
ERASCA INC
|
Healthcare | 0.00% | 0.76% |
Sold All 😨
(Was: #32) |
0.3 | -1,369,748 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APRE
APREA THERAPEUT...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #47) |
0.3 | -112,223 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 77 holdings